Skip to main content
SpringerLink
Log in

Molecular Pathology Laboratory Management

  • Chapter
Molecular Pathology in Clinical Practice

  • 1982 Accesses

Abstract

Currently more than 800 laboratories perform nucleic acid-based tests of human samples for the identification of genetic diseases, malignancies, infectious organisms, patient or sample identification, and human leukocyte antigen (HLA) typing.1 The operation of a clinical molecular pathology laboratory requires integration of expertise in medical, scientific, and clinical molecular pathology, resources including facilities, equipment, and personnel, and skills in organization, administration, management, and communication. Quality service is achieved by adherence to clinical laboratory regulations, from specimen collection and processing to reporting of patient results. This chapter reviews fundamental knowledge important for the management and operation of a clinical molecular pathology laboratory.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Klein M. Marketing research products to molecular pathologists. BioTactics in Action. 1998;1:1–5; Online Newsletter at www.biotactis.com/newsletter/v1i5/molbio.htm.

    Google Scholar 

  2. Grody WW, Matteson KJ, Murphy PD, et al. Molecular diagnostic methods for genetic diseases; approved guidelines. CLSI, MM1-A2. Vol 26. No. 27.Wayne PA, 2000.

    Google Scholar 

  3. Casey DK. Genes, dreams and reality. The promise and risks of the new genetics. Judicature. 1999;83:105–111.

    Google Scholar 

  4. Genetic Information Nondiscrimination Act of 2005 (S 306). Available at: http://www.govtrack.us/congress/bill.xpd?bill=s109-306.

    Google Scholar 

  5. Grody WW, Noll WW. Molecular diagnosis of genetic diseases. In: Henry JB, ed. Clinical Diagnosis and Management by Laboratory Methods. Philadelphia: WB Saunders; 2001:1372–1381.

    Google Scholar 

  6. Giardiello FM, Bresinger JD, et al. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med. 1997;336:823–827.

    Article  PubMed  CAS  Google Scholar 

  7. National Human Genome Research Institute. Promoting Safe and Effective Genetic Testing: Final Report of the Task Force on Genetic Testing. Bethesda, MD: National Human Genome Research Institute; 1997.

    Google Scholar 

  8. US Department of Health and Human Services, Centers for Disease Control and Prevention. Notice of intent: genetic testing under the Clinical Laboratory Improvement Amendments. Fed Regist. 2000;65:25928–25934.

    Google Scholar 

  9. Health Insurance Portability and Accountability Act of 1996. Public Law 104-191. 104th Congress (August 21, 1996). Available at: http://aspe.hhs.gov/admnsimp/pl104191.htm.

    Google Scholar 

  10. Gulley ML. Leukemias and lymphomas. In: Leonard DGB, ed. Diagnostic Molecular Pathology. Philadelphia: WB Saunders; 2003:113–127.

    Google Scholar 

  11. Barr FG, Ladanyi M. Sarcomas. In: Leonard DGB, ed. Diagnostic Molecular Pathology. Philadelphia: WB Saunders; 2003:53–76.

    Google Scholar 

  12. Fallon KB, Palmer CA, Roth KA, et al. Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas. J Neuropathol Exp Neurol. 2004;63:314–322.

    PubMed  CAS  Google Scholar 

  13. Unger ER, Guarner J. Infectious diseases. In: Leonard DGB, ed. Diagnostic Molecular Pathology. Philadelphia: WB Saunders; 2003:129–141.

    Google Scholar 

  14. Van Deerlin V. Identity testing: applications of DNA typing in anatomic pathology. In: Leonard DGB, ed. Diagnostic Molecular Pathology. Philadelphia: WB Saunders; 2003:163–188.

    Google Scholar 

  15. Clinical Laboratory Improvement Amendments (CLIA) of 1988. Public Law 100-578. 100th Congress (October 31, 1988). Available at: http://www.cms.hhs.gov/clia.

    Google Scholar 

  16. Ehrmeyer SS, Laessig HR. Compliance issues-the regulations. In: Harmening DM, ed. Laboratory Management Principles and Processes. Upper Saddle River, NJ: Prentice-Hall; 2003:225–243.

    Google Scholar 

  17. US Department of Health and Human Services. Medicare and CLIA programs. Regulations implementing the Clinical Laboratory Improvement of 1988 (CLIA). Fed Regist. 1992;57:7002–7186.

    Google Scholar 

  18. US Department of Health and Human Services. Medicare and CLIA Programs. Regulations implementing the Clinical Laboratory Improvement of 1988 (CLIA). Fed Regist. 2003;68:3639–3714.

    Google Scholar 

  19. Hoeltge GA, Dynek DA, Delaharty DC, et al. Clinical laboratory technical procedure manuals approved guidelines. Wayne, PA: National Committee for Clinical Laboratory Standards; 1996. Document GP-2A3-P.

    Google Scholar 

  20. Kaul KL, Leonard DG, Gonzales A, Garrett CT. Oversitght of genetic testing: an update. J Mol Diag. 2001;3:85–91.

    CAS  Google Scholar 

  21. Food and Drug Administration. Medical devices: classification/reclassification: restricted devices: analyte specific reagents. Fed Regist. 1997;62:62243–62260.

    Google Scholar 

  22. Takes PA, Murray G. The analyte specific reagent rule: a new set of regulations for labs, manufacturers. Clin Lab News. 1998;24:10.

    Google Scholar 

  23. Ferreira-Gonzales A. Establishing a molecular diagnostics laboratory. In: Henry JB, ed. Clinical Diagnosis and Management by Laboratory Methods. Philadelphia: WB Saunders. 2001:1333–1339.

    Google Scholar 

  24. Dadoun R. Impact on human resources: Core laboratory versus laboratory information system versus modular robotics. Clin Lab Manage Rev. 1998;12:248–255.

    PubMed  CAS  Google Scholar 

  25. Udaykumar E, Epstein JS, Hewlett IK. A novel method employing UNG to avoid carry-over contamination in RNA-PCR. Nucleic Acids Res. 1993;21:3917–3918.

    Article  PubMed  CAS  Google Scholar 

  26. Dumler S, Fink LM, Frank TS, et al. Goals and objectives for molecular pathology education in residency programs. J Mol Diag. 1999;1:5–15.

    Google Scholar 

  27. Killeen AA, Leung WC, Payne D, et al. Certification in molecular pathology in the United States (Training and Education Committee, The Association for Molecular Pathology). J Mol Diagn. 2002;4:181–184.

    PubMed  Google Scholar 

  28. Griffey PA. Fundamentals of financial management. In: Harmening DM, ed. Laboratory Management: Principles and Processes. Upper Saddle River, NJ: Prentice-Hall; 2003:163–179.

    Google Scholar 

  29. American Medical Association. 2006 CPT. Current Pnocedural Terminology (Professional Edition). Pathology and Laboratory Medicine Guidelines. Chicago: Americian Medical Association; 2005.

    Google Scholar 

  30. Grody WW, Cutting GR, Klinger KW, Richards CS, Watson MS, Desnick RJ. Laboratory standards and guidelines for population-based cystic fibrosis screening. Genet Med. 2001;3:149–154.

    Article  PubMed  CAS  Google Scholar 

  31. LaboratoryAccreditation Program—College of American Pathologists. Molecular Pathology checklist. Northfield, IL: College of American Pathologists; 2005.

    Google Scholar 

  32. Department of Health and Human Services, Centers for Disease Control and Prevention. Subpart Q—Inspection. Fed Regist. 1998;63:986–987.

    Google Scholar 

  33. Department of Health and Human Services. CLIA Program: approval of the Joint Commission on Accreditation of Healthcare Organizations as an accrediting organization. Fed Regist. 1995;60:130–132.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Molecular Pathology Laboratory, Department of Pathology and Laboratory Medicine, New York Presbyterian Hospital, Weill Medical College of Cornell University, New York, NY, 10021, USA

    Hanna Rennert PhD, FACMG (Director)

  2. Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, NY, 10021, USA

    Debra G. B. Leonard MD, PhD (Professor and Vice Chair for Laboratory Medicine)

Authors
  1. Hanna Rennert PhD, FACMG
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Debra G. B. Leonard MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University and New York Presbyterian Hospital, New York, NY, 10021, USA

    Debra G. B. Leonard MD, PhD (Professor and Vice Chair for Laboratory Medicine) (Professor and Vice Chair for Laboratory Medicine)

  2. Hematology, Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA

    Adam Bagg MD (Director) (Director)

  3. Department of Pathology and Laboratory Medicine, Emory University Hospital, Atlanta, GA, 30322, USA

    Angela M. Caliendo MD, PhD (Vice Chair and Associate Professor) (Vice Chair and Associate Professor)

  4. Northwestern University Feinberg School of Medicine, Evanston, IL, 60201

    Karen L. Kaul MD, PhD (Professor) (Professor)

  5. Department of Pathology and Laboratory Medicine, Evanston Northwestern Healthcare, Evanston, IL, 60201, USA

    Karen L. Kaul MD, PhD (Professor) (Professor)

  6. Molecular Pathology Laboratory, Department of Pathology and Laboratory Medicine, University of Pennsylvania Health System, Philadelphia, PA, 19104, USA

    Vivianna M. Van Deerlin MD, PhD (Director) (Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Rennert, H., Leonard, D.G.B. (2007). Molecular Pathology Laboratory Management. In: Leonard, D.G.B., Bagg, A., Caliendo, A.M., Kaul, K.L., Van Deerlin, V.M. (eds) Molecular Pathology in Clinical Practice. Springer, New York, NY. https://doi.org/10.1007/978-0-387-33227-7_49

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-33227-7_49

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-33226-0

  • Online ISBN: 978-0-387-33227-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation